Averto Medical
PrivateLast Round
Grant
Oct 6, 2025
Total Funding Raised
$38.45M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Averto Medical operates in Healthcare & Life Sciences and is based in Fremont, California. Its latest recorded funding round was a Grant round in October 2025.
Averto Medical is a clinical-stage medical technology company that develops minimally invasive devices for gastrointestinal care, specifically focusing on its ColoSeal intraluminal colonic diversion system to eliminate the need for temporary ostomies in colorectal surgery patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Averto Medical Comparables
Compare Averto Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SafeHeal | 91% | |
| SafeGuard Surgical | 89% | |
| Galmed Pharmaceuticals Ltd. | 87% |
For institutional investors. Book with your work email.
Averto Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 6, 2025 | ||||
| Grant | Sep 1, 2024 | ||||
| Series A | May 7, 2024 | ||||
| Seed | Nov 28, 2023 | ||||
| Grant | Nov 30, 2021 |
For institutional investors. Book with your work email.
Averto Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| LifeSci Venture Partners | Series A |
| NIH RADx | Grant |
| AlwaysraiseVentures | Seed |
| Synergy Ventures | Seed |
| Life Science Angels | Seed |
| Venrock | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2026
Grew 30% QoQ, from 10 to 13 employees.
- Aug 1, 2026
Grew 56% QoQ, from 9 to 14 employees.
For institutional investors. Book with your work email.
Averto Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Averto Medical's valuation, stock price, and market status.
Is Averto Medical a public or private company?
Averto Medical is a private company.
What is the current stock price of Averto Medical?
Averto Medical is a private company, so its shares have no public market price. Caplight tracks Averto Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Averto Medical worth (valuation)?
Valuation information for Averto Medical is not publicly available.
Can I buy Averto Medical stock?
Averto Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Averto Medical's last funding round?
Averto Medical's most recent funding round was Grant on October 6, 2025.
Who are the main investors in Averto Medical?
Key investors in Averto Medical include National Cancer Institute, NIH RADx, AlwaysraiseVentures, Cormorant Asset Management, National Science Foundation.
Will Averto Medical IPO soon?
No public IPO plans have been announced for Averto Medical.
How can I track Averto Medical secondary market activity?
Caplight tracks bids, offers, and trades in Averto Medical's shares on secondary markets.